XML 51 R33.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Schedule of cash and cash equivalents
Cash, cash equivalents and restricted cash consist of the following:
March 31,
2024
December 31,
2023
Cash and cash equivalents$190,690 $231,964 
Restricted cash1,889 1,875 
Total cash, cash equivalents and restricted cash$192,579 $233,839 
Restrictions on cash and cash equivalents
Cash, cash equivalents and restricted cash consist of the following:
March 31,
2024
December 31,
2023
Cash and cash equivalents$190,690 $231,964 
Restricted cash1,889 1,875 
Total cash, cash equivalents and restricted cash$192,579 $233,839 
Schedule of securities and other investments owned and securities sold not yet purchased at fair value
As of March 31, 2024 and December 31, 2023, the Company’s securities and other investments owned and securities sold not yet purchased at fair value consisted of the following securities:
March 31,
2024
December 31,
2023
Securities and other investments owned:
Equity securities$869,137 $994,634 
Corporate bonds56,616 59,287 
Other fixed income securities5,151 2,989 
Partnership interests and other18,964 35,196 
$949,868 $1,092,106 
Securities sold not yet purchased:
Equity securities$2,609 $1,037 
Corporate bonds2,592 5,971 
Other fixed income securities1,222 1,593 
$6,423 $8,601 
Equity method investments The financial information of these five investments has been aggregated and included below for purposes of the disclosure a quarter in arrears (balance sheet amounts as of December 31, 2023 and September 30, 2023 correspond to amounts as of March 31, 2024 and December 31, 2023, respectively, of the Company; income statement amounts during the three months ended December 31, 2023 and 2022 correspond to amounts during the three months ended March 31, 2024 and 2023, respectively, of the Company), which is the period in which the most recent financial information is available:
December 31,September 30,
20232023
Current assets$47,356 $51,588 
Noncurrent assets$266,995 $269,809 
Current liabilities$9,524 $8,594 
Noncurrent liabilities$621 $760 
Equity attributable to investee$301,380 $309,167 
Noncontrolling interest$2,826 $2,876 
For the three months ended December 31,
2023(1)
2022
Revenues$33,966 $27,971 
Cost of revenues$19,069 $16,387 
Net income attributable to investees$15,152 $11,808 
(1) - Financial information for 2023 includes two additional investments as a result of the acquisition of a majority ownership interest in bebe stores, inc (“bebe”) in 2023 and an other investment made in 2023.
The following tables contain summarized financial information with respect to Freedom VCM, included below for purposes of the disclosure a quarter in arrears (balance sheet amounts as of December 31, 2023 and September 30, 2023 correspond to amounts as of March 31, 2024 and December 31, 2023, respectively, of the Company; income statement amounts during the three months ended December 31, 2023 correspond to amounts during the three months ended March 31, 2024 of the Company), which is the period in which the most recent financial information is available:
December 31, 2023September 30, 2023
Current assets$961,787 $1,219,682 
Noncurrent assets$3,131,506 $3,142,660 
Current liabilities$720,510 $749,894 
Noncurrent liabilities$2,640,805 $2,695,445 
Equity attributable to investee$731,978 $917,003 
For the three months ended December 31,
2023
Revenues$806,229 
Cost of revenues$499,679 
Loss from continuing operations$(1,175)
Net loss attributable to investees$(169,583)
The following tables contain summarized financial information with respect to B&W included below for purposes of the disclosure a quarter in arrears (balance sheet amounts as of December 31, 2023 and September 30, 2023 correspond to amounts as of March 31, 2024 and December 31, 2023, respectively, of the Company; income statement amounts during the three months ended December 31, 2023 and 2022 correspond to amounts during the three months ended March 31, 2024 and 2023, respectively, of the Company), which is the period in which the most recent financial information is available:
December 31, 2023September 30, 2023
Current assets$497,593 $542,300 
Noncurrent assets$278,105 $294,979 
Current liabilities$350,197 $393,539 
Noncurrent liabilities$625,851 $585,430 
Equity attributable to investee$(200,961)$(142,316)
Noncontrolling interest$611 $626 

For the three months ended December 31,
20232022
Revenues$227,167 $236,424 
Cost of revenues$171,552 $182,760 
Loss from continuing operations$(54,266)$(2,289)
Net (loss) income$(62,724)$5,660 
Net (loss) income attributable to investees$(66,454)$2,021 
The following tables contain summarized financial information with respect to Synchronoss Technologies, Inc., included below for purposes of the disclosure a quarter in
arrears (balance sheet amounts as of December 31, 2023 and September 30, 2023 correspond to amounts as of March 31, 2024 and December 31, 2023, respectively, of the Company; income statement amounts during the three months ended December 31, 2023 and 2022 correspond to amounts during the three months ended March 31, 2024 and 2023, respectively, of the Company), which is the period in which the most recent financial information is available:
Synchronoss Technologies, Inc.
December 31, 2023September 30, 2023
Current assets$82,002 $85,903 
Noncurrent assets$228,335 $275,304 
Current liabilities$47,697 $74,528 
Noncurrent liabilities$164,706 $166,673 
Equity attributable to investee$97,934 $120,006 
Synchronoss Technologies, Inc.
For the three months ended December 31,
20232022
Revenues$41,402 $41,252 
Cost of revenues$10,292 $11,999 
Net loss attributable to investees$(35,001)$(15,927)
The following table contains summarized financial information for these companies, included below for purposes of the disclosure a quarter in arrears (balance sheet amounts as of December 31, 2023 and September 30, 2023 correspond to amounts as of March 31, 2024 and December 31, 2023, respectively, of the Company; income statement amounts during the three months ended December 31, 2023 and 2022 correspond to amounts during the
three months ended March 31, 2024 and 2023, respectively, of the Company), which is the period in which the most recent financial information is available:
December 31, 2023September 30, 2023
Current assets$279,810 $281,610 
Noncurrent assets$622,632 $627,858 
Current liabilities$185,925 $150,114 
Noncurrent liabilities$236,829 $277,638 
Preferred stock$4,500 $4,500 
Equity attributable to investee$475,188 $477,216 
For the three months ended December 31,
20232022
Revenues$170,034 $37,924 
Cost of revenues145,288 $33,062 
Net loss attributable to investees(852)$(13,613)
Equity Securities without readily determinable fair value The following table presents, as of March 31, 2024 and December 31, 2023, the carrying value of equity securities measured under the measurement alternative investments and the related adjustments recorded during the periods presented for those securities with observable price changes:
March 31,
2024
December 31,
2023
Securities and other investments owned, carrying value$68,135 $64,455 
Upward carrying value changes928 100 
Downward carrying value changes/impairment(2)(21,395)
Schedule of financial assets and liabilities measured on recurring basis
The following tables present information on the financial assets and liabilities measured and recorded at fair value on a recurring basis as of March 31, 2024 and December 31, 2023.
Financial Assets and Liabilities Measured at Fair Value on a
Recurring Basis as of March 31, 2024 Using
Fair value as of March 31, 2024
Quoted prices in active markets
for identical assets
 (Level 1)
Other observable inputs
 (Level 2)
Significant unobservable inputs
 (Level 3)
Assets:
Securities and other investments owned:
Equity securities$801,002 $126,323 $— $674,679 
Corporate bonds56,616 51,566 5,050 — 
Other fixed income securities5,151 — 5,151 — 
Total securities and other investments owned862,769 177,889 10,201 674,679 
Loans receivable, at fair value452,496 — — 452,496 
Total assets measured at fair value$1,315,265 $177,889 $10,201 $1,127,175 
Liabilities:
Securities sold not yet purchased:
Equity securities$2,609 $2,609 $— $— 
Corporate bonds2,592 36 2,556 — 
Other fixed income securities1,222 — 1,222 — 
Total securities sold not yet purchased6,423 2,645 3,778 — 
Mandatorily redeemable noncontrolling interests issued after November 5, 20035,601 — — 5,601 
Contingent consideration29,322 — — 29,322 
Total liabilities measured at fair value$41,346 $2,645 $3,778 $34,923 
Financial Assets and Liabilities Measured at Fair Value on a
Recurring Basis at December 31, 2023 Using
Fair value at December 31, 2023
Quoted prices in active markets
for identical assets
 (Level 1)
Other observable inputs
 (Level 2)
Significant unobservable inputs
 (Level 3)
Assets:
Securities and other investments owned:
Equity securities$930,179 $194,541 $— $735,638 
Corporate bonds59,287 56,045 3,242 — 
Other fixed income securities2,989 — 2,989 — 
Total securities and other investments owned992,455 250,586 6,231 735,638 
Loans receivable, at fair value532,419 — — 532,419 
Total assets measured at fair value$1,524,874 $250,586 $6,231 $1,268,057 
Liabilities:
Securities sold not yet purchased:
Equity securities$1,037 $1,037 $— $— 
Corporate bonds5,971 — 5,971 — 
Other fixed income securities1,593 — 1,593 — 
Total securities sold not yet purchased8,601 1,037 7,564 — 
Mandatorily redeemable noncontrolling interests issued after November 5, 20035,835 — — 5,835 
Contingent consideration27,985 — — 27,985 
Total liabilities measured at fair value$42,421 $1,037 $7,564 $33,820 
Schedule of fair value measurement inputs and valuation techniques
The following table summarizes the significant unobservable inputs in the fair value measurement of Level 3 financial assets and liabilities by category of investment and valuation technique as of March 31, 2024 and December 31, 2023:
Fair value at March 31,
2024
Valuation
Technique
Unobservable
Input
Range
Weighted
Average(1)
Assets:
Equity securities$572,900 Market approachMultiple of EBITDA
2.3x - 9.0x
8.1x
Multiple of Sales
0.7x - 3.8x
0.9x
Market price of related security
$0.05 - $11.20
$10.74
58,579 Discounted cash flowMarket interest rate
20.2% - 21.3%
21.2%
43,200 Option pricing modelAnnualized volatility
25.0% - 188.0%
73.0%
Loans receivable at fair value220,659 Discounted cash flowMarket interest rate
13.9% - 27.2%
18.4%
231,837 Market approachMarket price of related security$17.22$17.22
Multiple of Sales
0.6x - 0.7x
0.7x
Total level 3 assets measured at fair value$1,127,175 
Liabilities:
Mandatorily redeemable noncontrolling interests issued after November 5, 2003$5,601 Market approachOperating income multiple
6.0x
6.0x
Contingent consideration29,322 Discounted cash flowEBITDA volatility70.0%70.0 %
Asset volatility69.0%69.0 %
Market interest rate8.5%8.5 %
Total level 3 liabilities measured at fair value$34,923 Revenue volatility
5.0% - 6.3%
5.6 %
(1) - Unobservable inputs were weighted by the relative fair value of the financial instruments.
Fair value at December 31,
2023
Valuation TechniqueUnobservable InputRange
Weighted
Average(1)
Assets:
Equity securities$662,158 Market approachMultiple of EBITDA
0.7x - 13.5x
7.1x
Multiple of Sales
0.8x to 3.8x
1.0x
Market price of related security
$0.04 - $92.51
$12.27
58,331 Discounted cash flowMarket interest rate
20.2% - 57.0%
24.6%
15,149 Option pricing modelAnnualized volatility
25.0% - 187.0%
75.0%
Loans receivable at fair value512,522 Discounted cash flowMarket interest rate
10.0% - 41.6%
17.1%
19,897 Market approachMarket price of related security$19.87$19.87
Total level 3 assets measured at fair value$1,268,057 
Liabilities:
Mandatorily redeemable noncontrolling interests issued after November 5, 2003$5,835 Market approachOperating income multiple
6.0x
6.0x
Contingent consideration27,985 Discounted cash flowEBITDA volatility70%70%
Asset volatility69%69%
Market interest rate8.5%8.5%
Revenue volatility5.1%5.1%
Total level 3 liabilities measured at fair value$33,820 
(1) - Unobservable inputs were weighted by the relative fair value of the financial instruments.
Schedule of fair value measurement of level 3 financial assets and liabilities
The changes in Level 3 fair value hierarchy during the three months ended March 31, 2024 and 2023 were as follows:
Level 3
Balance at
Beginning of
Period
Level 3 Changes During the PeriodLevel 3
Balance at
End of
Period
Fair
Value
Adjustments (1)
Relating to
Undistributed
Earnings
Purchases,
Sales and
Settlements
Transfer in
and/or out
of Level 3
Three Months Ended March 31, 2024
Equity securities$735,638 $(51,009)$12 $(8,888)$(1,074)$674,679 
Loans receivable at fair value532,419 (12,130)3,089 (70,882)— 452,496 
Mandatorily redeemable noncontrolling interests issued after November 5, 20035,835 — 293 (527)— 5,601 
Contingent consideration27,985 1,407 — (70)— 29,322 
Three Months Ended March 31, 2023
Equity securities$368,465 $(9,016)$— $6,487 $(6,895)$359,041 
Loans receivable at fair value701,652 43,459 231 26,743 — 772,085 
Mandatorily redeemable noncontrolling interests issued after November 5, 20034,648 — 308 (302)— 4,654 
Contingent consideration31,046 (3,447)— 1,285 — 28,884 
(1) - Fair value adjustments represent realized and unrealized gains (losses) of which $(10,390) relating to equity securities and $(12,130) relating to loans receivable, at fair value were included in trading income (loss) and fair value adjustments on loans and $(40,619) relating to equity securities were included in realized and unrealized gains (losses) on investments in the condensed consolidated statement of operations during the three months ended March 31, 2024. Fair value adjustments represent realized and unrealized gains (losses) of which $(12) relating to equity securities and $43,459 relating to loans receivable, at fair value were included in trading income (loss) and fair value adjustments on loans and $(9,004) relating to equity securities were included in realized and unrealized gains (losses) on investments in the condensed consolidated statement of operations during the three months ended March 31, 2023.
Schedule of financial assets measured on nonrecurring basis
The following table presents information on the assets measured at fair value on a nonrecurring basis by level within the fair value hierarchy as of March 31, 2024 and December 31, 2023. These investments were measured due to an observable price change or impairment during the periods below.
Fair Value Measurement Using
TotalQuoted prices in active markets
for identical assets
 (Level 1)
Other observable inputs
 (Level 2)
Significant unobservable inputs
 (Level 3)
As of March 31, 2024
Investments in nonpublic entities that do not report NAV$3,424 $— $3,424 $— 
As of December 31, 2023
Investments in nonpublic entities that do not report NAV$1,628 $— $1,602 $26 
Schedule of investments in the VIE
March 31,
2024
December 31,
2023
Securities and other investments owned, at fair value$14,538 $28,573 
Loans receivable, at fair value247,115 250,801 
Other assets17,594 11,418 
Maximum exposure to loss$279,247 $290,792